Denali Advisors LLC Cooper Companies, Inc. Transaction History

Denali Advisors LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 19, 2024	BUY	$306.88 - $380.0 $276,192 - $342,000	900 Added 900.0%	1,000 $378,000
Q3 2023 Oct 19, 2023	SELL	$315.92 - $397.36 $315 - $397	-1 Reduced 0.99%	100 $31,000
Q1 2023 Apr 21, 2023	BUY	$323.56 - $373.36 $323 - $373	1 Added 1.0%	101 $37,000
Q4 2022 Feb 09, 2023	BUY	$248.67 - $334.17 $24,867 - $33,417	100 New	100 $33,000
Q3 2018 Oct 09, 2018	SELL	$236.3 - $277.15 $212,670 - $249,434	-900 Closed	0 $0
Q2 2018 Jul 11, 2018	SELL	$217.98 - $237.23 $87,192 - $94,892	-400 Reduced 30.77%	900 $212,000
Q1 2018 Apr 23, 2018	SELL	$218.74 - $251.43 $87,496 - $100,572	-400 Reduced 23.53%	1,300 $297,000
Q4 2017 Jan 24, 2018	BUY	$217.88 - $244.43 $370,396 - $415,531	1,700	1,700 $370,000

1.59M

Ticker COO
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 49,346,000
Market Cap $4.92B
Description
The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses corr...

Get notified when there are updates to the investment portfolio of Denali Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Denali Advisors LLC with notifications on news.